Nuance Pharma
PrivateLast Round
Series E
Jul 22, 2025
Est. Valuation
$620.7M
Total Funding Raised
$216M
Company Overview
Nuance Pharma is a specialty pharmaceutical company that develops and commercializes innovative therapies for respiratory, emergency care, iron deficiency anemia, and pain management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuance Pharma Comparables
Compare Nuance Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SciClone Pharmaceuticals (Holdings) Limited | 70% | |
| Zai Lab Limited | 69% | |
| Stallergenes Greer | 67% |
Nuance Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jul 22, 2025 | ||||
| Strategic | Jun 10, 2021 | ||||
| Series D | Dec 8, 2020 | ||||
| Series B | Jun 27, 2018 |
Key People
Founding team and executive leadership
Nuance Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CBC Group | Series D, Series B |
| HBM Healthcare Investments | Series D, Series B |
| MPC | Series D |
| RTW Investments | Series D |
| nebag ag | Series B |
| HBM Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2024
Ohtuvayre launched via early access in Hainan Boao Pilot Zone.
- Jun 10, 2021
$15M raised with Verona Pharma plc
Nuance Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nuance Pharma's valuation, stock price, and market status.
Is Nuance Pharma a public or private company?
Nuance Pharma is a private company.
What is the current stock price of Nuance Pharma?
Nuance Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Nuance Pharma worth (valuation)?
Nuance Pharma's valuation is estimated at $620.7M based on funding round data.
Can I buy Nuance Pharma stock?
Nuance Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nuance Pharma's last funding round?
Nuance Pharma's most recent funding round was Series E on July 22, 2025.
Who are the main investors in Nuance Pharma?
Key investors in Nuance Pharma include CBC Group.
Will Nuance Pharma IPO soon?
No public IPO plans have been announced for Nuance Pharma.
How can I track Nuance Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nuance Pharma's secondary market activity and sign up for updates.